Stocks● Neutral
FORE Biotherapeutics Closes $67.4M Series D-2 Extension
FORE Biotherapeutics raised $67.4M in an upsized Series D-2 extension, bringing the round to $110M. SR One, Medicxi, and SymBiosis co-led the financing.
Continue with
AlphaScala Research Snapshot
Live stock context for companies directly referenced in this story
Alpha Score of 80 reflects strong overall profile with strong momentum, strong value, moderate quality, moderate sentiment.
Alpha Score
80
Strong
This panel uses AlphaScala-native stock data — proprietary scoring and live snapshots.
FORE Biotherapeutics closed an upsized Series D-2 extension financing of $67.4 million, bringing the total raised in the round to $110 million. The Philadelphia-based company is developing targeted therapies for cancer patients and is at the registration stage.
The extension was co-led by SR One, Medicxi, and SymBiosis. New investors included TaiAx, LG Technology Ventures, Primer Ventures, and Axil. All existing investors participated, among them OrbiMed Advisors, HBM Healthcare Investments, Wellington Management, Cormorant Capital, Novartis Venture Fund, Windham Life Science Partners, Samsung, and 3B Capital.
How this story was producedLast reviewed Jul 14, 2026
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.
Explore More
More from AlphaScala
Indices
Micron (MU) Breaks Ground on $9B Japan Chip Plant
Jul 4
CommoditiesHudbay Locks 4.50% on $52M Arizona IDA Bonds for Copper World
Jun 17
StocksBoeing Locks $3B Revolver, $5B Liquidity Covenant After Expired Facility
Aug 29
StocksSalesforce data hits 40GB as agents rewrite CRM storage math
Aug 28
StocksExelon CFO Jones Steps Into New Finance and Strategy Role Oct. 5
Aug 28
StocksTokenized deposits risk $580B U.S. bank lending cut: report
Aug 28
Trading Q&A
How to start trading stocks as a beginner?
What is the S&P 500 index?
What is an ETF and how does it work?
What is a hedge fund?